Abstract:Increasing evidence demonstrates that antigen-specific cellular and humoral immunity plays an indispensable role in protection against Mycobacterium tuberculosis infection. Antigen is a key element in the development of a successful diagnostic method and vaccine. However, few antigens are available, and a systemic study on M. tuberculosis ORFeome-based antigen screening is still lacking. In the current study, a genome-wide examination was conducted on high-throughput M. tuberculosis encoding proteins and novel antigens were identified via a comprehensive investigation of serological and antigen-specific cellular responses. The serological immunoglobulin G level of each protein was detected in pooled sera from 200 pulmonary tuberculosis patients by means of semi-quantitative Western blot. Of the 1,250 detected proteins, 29 were present at a higher level relative to the commercialized 38-kDa protein. Furthermore, the top 12 of the 29 proteins had not been previously reported, and their antigenicity was validated in serum from each individual patient. Results confirmed that the 12 proteins displayed nearly identical immunoglobulin G antibody levels in patients with pulmonary and extrapulmonary tuberculosis. Antigen-specific cellular interferon-γ secretion was also evaluated using a cell-based ELISPOT assay. Thirty-four of the proteins were able to induce positive interferon-γ production by peripheral blood mononuclear cells from pulmonary tuberculosis patients as judged by positive (commercial ESAT-6 antigen) and negative controls. The top 4 candidates out of the 34 proteins displayed good accuracy ranging from 50% to 80% compared with the commercial ESAT-6 antigen. Subsequent epitope examination confirmed that a pool of peptides, including a 25aa peptide from Rv1198, demonstrated significant tuberculosis-specific cellular interferon-γ production. Overall, the current study draws significant attention to novel M. tuberculosis antigens, many of which have not been previously reported. This discovery provides a large amount of useful information for the diagnosis of tuberculosis and the development of vaccines to provide protection against tuberculosis.

Identification of a Novel Serum Biomarker for Tuberculosis Infection in Chinese HIV Patients by Itraq-Based Quantitative Proteomics.

Discovery of Potential Plasma Biomarkers for Tuberculosis in HIV-Infected Patients by Data-Independent Acquisition-Based Quantitative Proteomics.

Discovery and Identification of Serum Potential Biomarkers for Pulmonary Tuberculosis Using Itraq-Coupled Two-Dimensional Lc-Ms/Ms

Characterization of cytokine profile to distinguish latent tuberculosis from active tuberculosis and healthy controls.

Proteomic Profiling for Plasma Biomarkers of Tuberculosis Progression

Serum cytokine biosignatures for identification of tuberculosis among HIV-positive inpatients

Identification of Potential Urine Proteins and Microrna Biomarkers for the Diagnosis of Pulmonary Tuberculosis Patients.

Serum protein S100A9, SOD3, and MMP9 as new diagnostic biomarkers for pulmonary tuberculosis by iTRAQ-coupled two-dimensional LC-MS/MS.

Data-Independent Acquisition Strategy For The Serum Proteomics Of Tuberculosis

Development And Evaluation Of A New Interferon-Gamma Release Assay For The Diagnosis Of Tuberculosis Infection In Hiv-Infected Individuals In China

Identification of putative biomarkers for the serodiagnosis of drug-resistant Mycobacterium tuberculosis

Label-Free Quantitative Proteomics Identifies Novel Plasma Biomarkers for Distinguishing Pulmonary Tuberculosis and Latent Infection

The Discovery and Identification of a Candidate Proteomic Biomarker of Active Tuberculosis

Exploration of novel cellular and serological antigen biomarkers in the ORFeome of Mycobacterium tuberculosis.

Urinary proteomic analysis to identify a potential protein biomarker panel for the diagnosis of tuberculosis

Identification of New Diagnostic Biomarkers for Mycobacterium Tuberculosis and the Potential Application in the Serodiagnosis of Human Tuberculosis

Specific T-cell Responses to CFP10, an Secreted Antigens of Mycobacterium Tuberculosis Protein, in Chinese HIV Positive Individuals

Profiling the human immune response to Mycobacterium tuberculosis by human cytokine array

ORFeome-based Identification of Biomarkers for Serodiagnosis of Mycobacterium Tuberculosis Latent Infection

Multiplex Analysis of Plasma Cytokines/chemokines Showing Different Immune Responses in Active TB Patients, Latent TB Infection and Healthy Participants.

Screening and identification of a six-cytokine biosignature for detecting TB infection and discriminating active from latent TB